Bluebird Bio Inc (BLUE)

[stocksrising]

Adam F confirmed what/why sell off


$VRTX $CRSP Casgevy $2.2 million, no black box.

$BLUE Lyfengia $3.1 million, black box.

Bluebird will have to lower its price, right? How can it not?

Also, Bluebird confirmed to us that it DID NOT get a pediatric rare disease voucher for this approval.

Recall, the company had presold the voucher for $100M, assuming it would get one.